Immobilized transaminases and process for making and using immobilized transaminase
US-2015368682-A1 · Dec 24, 2015 · US
US10501762B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10501762-B2 |
| Application number | US-201615208573-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 12, 2016 |
| Priority date | Feb 18, 2014 |
| Publication date | Dec 10, 2019 |
| Grant date | Dec 10, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The disclosure generally relates to the fields of synthetic organic chemistry. In particular, the present disclosure relates to methods and systems for the imidation of sulfides.
Opening claim text (preview).
What is claimed is: 1. A method for catalyzing the intermolecular insertion of nitrogen into organosulfur substrates to produce a product having a new S-N bond, the method comprising: providing a mixture comprising a nitrene source, an organosulfur substrate and a heme enzyme comprising the amino acid sequence of SEQ ID NO: 1 or an engineered heme enzyme comprising the amino acid sequence of SEQ ID NO: 1 with the exception of at least one, two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, or all of the following amino acid substitutions in the amino acid sequence of SEQ ID NO: 1 L V78A, F87C, P142S, T175I, A184V, S226R, H236Q, T438S, E252G, A290V, L353V, I366V, C400X, T438S and E442K, wherein “X” is any amino acid other than Cys; and reacting said mixture for a time sufficient to form a product having a new S-N bond. 2. The method of claim 1 , wherein said nitrene source is an azide. 3. The method of claim 2 , wherein said azide has the general formula R 1 —N 3 , wherein R 1 is: (i) a substituted or unsubstituted aryl, a substituted or unsubstituted aryl, —OR 2 , or —NR 2 , wherein R 2 is a substituted or unsubstituted aryl, a substituted or unsubstituted alkyl; (ii) —SO 2 R 3 , wherein R 3 is a substituted or unsubstituted aryl, a substituted or unsubstituted alkyl, —OR 2 , or —NR 2 , wherein R 2 are any alkyl or aryl; (iii) —COR 4 , wherein R 4 is a substituted or unsubstituted aryl, a substituted or unsubstituted alkyl, —OR 2 , or —NR 2 , wherein R 2 are any alkyl or aryl; or (iv) —P(O)(OR 5 )(OR 6 ), wherein R 5 and R 6 are independently H, a substituted or unsubstituted aryl, a substituted or unsubstituted alkyl. 4. The method of claim 3 , wherein said azide has a structure selected from the group consisting of: wherein R 1 is any alkyl, aryl, —OR, NR 2 , wherein R, R 2 and R 3 are any alky, or aryl. 5. The method of claim 1 , wherein said nitrene source is selected from the group consisting of: wherein R 1 is any alkyl, aryl, —OR, NR 2 , wherein R, R 2 and R 3 are any alkyl, or aryl. 6. The method of claim 1 , wherein said product having a new S-N bond is an aliphatic amine and said nitrene source is tosyl azide. 7. The method of claim 1 , wherein said product having a new S-N bond is generated through a nitrenoid intermediate. 8. The method of claim 1 , further comprising expressing said heme enzyme in a bacterial, archaeal or fungal host organism. 9. The method of claim 1 , wherein said engineered heme enzyme comprises a T268A mutation, a T438S mutation and/or a C400X mutation in the amino acid sequence of SEQ ID NO: 1 , wherein X is any amino acid other than Cys. 10. The method of claim 1 , wherein said product having a new S-N bond is a compound of Formula Ia: wherein R 1 is a sulfoxide, a carbonyl or a phosphonate; wherein R 2 is H or any alkyl or aryl; and wherein R 3 is H, O or an optionally substituted aryl group. 11. The method of claim 10 , wherein R 1 is a sulfoxide of formula SO 2 R 5 , wherein R 5 is any alkyl, any aryl, —OR 6 or NR 7 , wherein R 6 and Ware any alkyl or any aryl. 12. The method of claim 10 , wherein W is a phosphonate of formula P(O)(OR 8 )(OR 9 ), wherein R 8 and R 9 are independently any aryl or any alkyl.
Amines; Imines · CPC title
NADPH-hemoprotein reductase (1.6.2.4), i.e. NADP-cytochrome P450-reductase · CPC title
Unspecific monooxygenase (1.14.14.1) · CPC title
Preparation of nitrogen-containing organic compounds · CPC title
NADPH-cytochrome P450 reductase (1.6.2.4) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.